October 4, 2024

Shocking Report Reveals 59% of Long COVID Patients Suffer From Organ Damage a Year Later

Of the 536 patients, 331 (62%) were related to organ problems 6 months after their initial diagnosis. These clients were followed up 6 months later with a 40-minute multi-organ MRI scan (Perspectums CoverScan), analyzed in Oxford.
The findings verified that 29% of clients with long COVID had multi-organ disability, with consistent symptoms and reduced function at six and 12 months. 59% of long COVID patients had single organ problems 12 months after preliminary medical diagnosis.
Senior author Professor Amitava Banerjee (UCL Institute of Health Informatics), said: “Symptoms prevailed at 6 and 12 months and related to female gender, more youthful age, and single organ problems.”
The research study reported a reduction in signs in between 6 and 12 months (severe shortness of breath from 38% to 30% of patients, cognitive dysfunction from 48% to 38% of patients, and poor health-related lifestyle from 57% to 45% of clients).
Professor Banerjee included: “Several research studies confirm persistence of signs in people with long COVID as much as one year. We now add that 3 in five people with long COVID have problems in at least one organ, and one in four have impairment in two or more organs, in many cases without symptoms.”
He stated: “Impact on lifestyle and time off work, particularly in healthcare employees, is a major issue for individuals, health systems and economies. Many healthcare employees in our study had no previous disease, however of 172 such participants, 19 were still symptomatic at follow-up and off work at a median of 180 days.”
The underlying systems of long COVID remain evasive, state the researchers, who did not discover proof by symptoms, blood examinations or MRI to clearly specify long Covid subtypes. They say that future research needs to think about associations in between symptoms, multi-organ disability and function in bigger mates.
Teacher Banerjee concluded: “Organ disability in long Covid has implications for symptoms, lifestyle and longer-term health, signifying the need for prevention and integrated care for long COVID clients.”
Reference: “Multi-organ disability and long COVID: a 1-year prospective, longitudinal cohort research study” by Andrea Dennis, Daniel J Cuthbertson, Dan Wootton, Michael Crooks, Mark Gabbay, Nicole Eichert, Sofia Mouchti, Michele Pansini, Adriana Roca-Fernandez, Helena Thomaides-Brears, Matt Kelly, Matthew Robson, Lyth Hishmeh, Emily Attree, Melissa Heightman, Rajarshi Banerjee and Amitava Banerjee, 14 February 2023, Journal of the Royal Society of Medicine.DOI: 10.1177/ 01410768231154703.

Long COVID, likewise understood as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition where people continue to experience signs or develop brand-new symptoms after recovering from severe COVID-19 infection. The symptoms of long COVID can be extensive and might include fatigue, shortness of breath, chest discomfort, joint discomfort, headache, brain fog, problem sleeping, and anxiety or anxiety. According to a recent comprehensive study on long COVID clients spanning over 12 months, 59% of clients continued to display organ damage a year after experiencing initial signs, including those who were not badly affected at the time of their virus diagnosis.
Organ damage continued 59% of long COVID patients a year after preliminary symptoms, even in those not seriously impacted when first identified with the infection, according to a comprehensive brand-new study.
A new thorough research study of organ disability in long COVID patients over 12 months reveals organ damage continued 59% of clients a year after preliminary symptoms, even in those not seriously impacted when very first detected with the infection.
The research study, released in the Journal of the Royal Society of Medicine, focused on patients reporting severe breathlessness, cognitive dysfunction, and poor health-related lifestyle; 536 long COVID clients were included in the study. Thirteen percent were hospitalized when first diagnosed with COVID-19, while 32% of individuals taking part in the study were health care employees.